Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2012 080 271.5 |
96 | EP file number | EAKZ | 19 17 9871.9 |
97 | EP publication number | EPN | 3564378 |
54 | Designation/title | TI | IMMUNOGENE ZUSAMMENSETZUNG |
51 | IPC main class | ICM (ICMV) | C12N 15/62 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 14/33 (2006.01), A61K 39/08 (2006.01), A61K 39/00 (2006.01), C07K 16/12 (2006.01), C12N 15/70 (2006.01) |
22 | DE application date | DAT | May 25, 2012 |
96 | EP application date | EAT | May 25, 2012 |
43 | Date of first publication | OT | Nov 6, 2019 |
| Date of publication of grant | PET | Nov 1, 2023 |
71/73 | Applicant/owner | INH | GlaxoSmithKline Biologicals SA, Rixensart, BE |
72 | Inventor | IN | Castado, Cindy, 1330 Rixensart, BE |
74 | Representative | VTR | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201161490734 P May 27, 2011
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201161490707 P May 27, 2011
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201161490716 P May 27, 2011
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003564378A1 Searchable text:
EP000003564378A1 Original document:
EP000003564378B1 Searchable text:
EP000003564378B1 |
43 | Date of first publication | EVT | Nov 6, 2019 |
| Date of the first transfer into DPMAregister | EREGT | Nov 6, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | May 8, 2025 (Show all update days)(Hide all update days)- May 8, 2025
- Procedures: Opposition procedure, Decision on revocation by EPO has become final, 12.12.2024: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 01.11.2023: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 01.11.2023: deleted
- Apr 3, 2025
- Status: changed
- Due date: deleted
- Procedures: Opposition procedure, Revocation by EPO, 12.12.2024: new
- Procedures: Opposition procedure, Decision on revocation by EPO has become final, 12.12.2024: new
- Jan 23, 2025
- St.36: changed (technical change)
- Nov 12, 2024
- Sep 19, 2024
- Procedures: Opposition procedure, Opposition filed, 25.07.2024: changed
- Aug 15, 2024
- Procedures: Opposition procedure, Opposition filed, 25.07.2024: new
- Jul 25, 2024
- St.36: changed (technical change)
- May 30, 2024; Apr 26, 2024; Jan 10, 2024; Nov 6, 2023; Oct 12, 2023
- Historical data not available for this/these date(s)
- Nov 6, 2019
- Date of the first transfer into DPMAregister
|